Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats

Table 6 Experimental groups used to evaluate the safety of interchangeable use of oral and subcutaneous administration of robenacoxib in cats

Group	Treatment	Multiples of MRD^a	Target daily oral dose level (mg/kg)	Target daily subcutaneousdose level / dose volume(mg/kg) / (mL/kg)	Number of cats
Group	Treatment	Multiples of MRD^a	Target daily oral dose level (mg/kg)		Males	Females
1	Control^b	0	0	0 / 0.3	5	5
2	Robenacoxib	1X	≥ 2.4	2.0 / 0.1	4	4
3	Robenacoxib	2X	≥ 4.8	4.0 / 0.2	4	4
4	Robenacoxib	3X	≥ 7.2	6.0 / 0.3	4	4

ISSN: 1746-6148